Todd Shriber

Todd Shriber

InvestorPlace Contributor

Recent Articles

2 ETFs to Ride the Bullishness in Facebook Stock

By Todd Shriber, InvestorPlace Contributor

Facebook stock is one of just six stocks trading on the Nasdaq that qualify for mega-cap status, and with more than 80 ETFs holding it, it's not surprising that they're riding a wave of bullishness in FB.

3 ETFs to Benefit From Monthly Dividend Stocks

By Todd Shriber, InvestorPlace Contributor

The advantages of monthly dividend stocks and ETFs are obvious. For investors needing current income, monthly dividend stocks increase frequency of payout. For younger, long-term investors, monthly dividend stocks and ETFs boost the power of compounding when those investors opt to reinvest dividends.

3 Funds That Give Utilities a Little Sex Appeal

By Todd Shriber, InvestorPlace Contributor

Utilities stocks have a boring reputation. These ETFs prove it doesn't have to be that way.

2 Long-Term MLPs Ripe for Income Investors

By Todd Shriber, InvestorPlace Contributor

There are roughly 25 MLP ETFs trading in the U.S. and it is accurate to say more than half of the MLP ETFs around today are successes, with over $25 billion in combined assets under management.

Bad Apples: AAPL Earnings Could Jolt These ETFs

By Todd Shriber, InvestorPlace Contributor

Investors are showing concern over AAPL before earnings. These ETFs might be the most at risk if Apple disappoints.

3 Emerging Markets ETFs to Feast On … If You Dare

By Todd Shriber, InvestorPlace Contributor

It takes a daring investor to get involved in emerging markets ETFs. Here are some emerging markets ETFs with solid results for risk-tolerant investors.

Bet on a Bounce with These Biotech ETFs

By Todd Shriber, InvestorPlace Contributor

Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain.

3 Preferred Stock ETFs to Power Up a Portfolio

By Todd Shriber, InvestorPlace Contributor

While the Fed dithers about raising interest rates, you can look to preferred-stock ETFs like PFF, VRP and PFXF.

Be Careful Before Loving Leveraged Biotech ETFs

By Todd Shriber, InvestorPlace Contributor

The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs.

What’s Next for European Currency Hedging?

By Todd Shriber, InvestorPlace Contributor

Think European stocks and currency hedging are dead? Actually, now may be the best time to buy into ETFs like HEDJ.

Load More